Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Study of Irinotecan Liposomes Combined With Bevacizumab in the Treatment of Progressive or Recurrent Glioma

NCT06801730 is registered in ClinicalTrials.gov with Zhifeng Tian,MD as lead sponsor.

NCT NCT06801730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06801730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Study of Irinotecan Liposomes Combined With Bevacizumab in the Treatment of Progressive or Recurrent Glioma
Lead sponsor
Zhifeng Tian,MD
Phase
Phase 2
Overall status
Recruiting
Start date
January 8, 2025
Completion date
December 15, 2026
Enrollment
38 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioma